β2-adrenergic receptor polymorphisms and signaling: Do variants influence the "memory" of receptor activation?

Science Signaling

Volumn 4, Issue 185, 2011, Pages

  Insel, Paul A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BETA 2 ADRENERGIC RECEPTOR; CYCLIC AMP; GLYCINE;

AMINO TERMINAL SEQUENCE; CELLULAR PARAMETERS; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; GENE SEQUENCE; HUMAN; IN VIVO STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FUNCTION; RECEPTOR ACTIVATION; RECEPTOR MEMORY; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; GENETIC POLYMORPHISM; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; CYCLIC AMP; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION;

EID: 80051642891     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2002352     Document Type: Review

References (30)

1. H. R. Bourne, G-proteins and GPCRs: From the beginning. Ernst Schering Found. Symp. Proc. 2, 1-21 (2006).
2. R. J. Lefkowitz, Seven transmembrane receptors: Something old, something new. Acta Physiol. (Oxf.) 190, 9-19 (2007).
3. Z. Selinger, Discovery of G protein signaling. Annu. Rev. Biochem. 77, 1-13 (2008).
4. S. Rajagopal, K. Rajagopal, R. J. Lefkowitz, Teaching old receptors new tricks: Biasing seventransmembrane receptors. Nat. Rev. Drug Discov. 9, 373-386 (2010).
5. M. C. Lagerström, H. B. Schiöth, Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat. Rev. Drug Discov. 7, 339-357 (2008).
6. J. P. Overington, B. Al-Lazikani, A. L. Hopkins, How many drug targets are there? Nat. Rev. Drug Discov. 5, 993-996 (2006).
7. P. A. Insel, A. Snead, F. Murray, L. Zhang, H. Yokouchi, T. Katakia, O. Kwon, D. Dimucci, A. Wilderman, GPCR expression in tissues and cells: Are the optimal receptors being used as drug targets? Br. J. Pharmacol. 10.1111/j.1476-5381.2011.01434 (2011).
8. S. G. Rasmussen, H. J. Choi, D. M. Rosenbaum, T. S. Kobilka, F. S. Thian, P. C. Edwards, M. Burghammer, V. R. Ratnala, R. Sanishvili, R. F. Fischetti, G. F. Schertler, W. I. Weis, B. K. Kobilka, Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450, 383-387 (2007).
9. M. Audet, M. Bouvier, Insights into signaling from the beta2-adrenergic receptor structure. Nat. Chem. Biol. 4, 397-403 (2008).
10. D. Wacker, G. Fenalti, M. A. Brown, V. Katritch, R. Abagyan, V. Cherezov, R. C. Stevens, Conserved binding mode of human beta2 adrenergic receptor inverse agonists and antagonist revealed by x-ray crystallography. J. Am. Chem. Soc. 132, 11443-11445 (2010).
11. 2 adrenergic receptor-Gs protein complex. Nature 19, 10.1038/nature10361 (2011).
12. V. E. Ortega, G. A. Hawkins, S. P. Peters, E. R. Bleecker, Pharmacogenetics of the beta 2-adrenergic receptor gene. Immunol. Allergy Clin. North Am. 27, 665-684, vii (2007).
13. G. A. Hawkins, K. Tantisira, D. A. Meyers, E. J. Ampleford, W. C. Moore, B. Klanderman, S. B. Liggett, S. P. Peters, S. T. Weiss, E. R. Bleecker, Sequence, haplotype, and association analysis of ADRbeta2 in a multiethnic asthma casecontrol study. Am. J. Respir. Crit. Care Med. 174, 1101-1109 (2006).
14. A. Panebra, W. C. Wang, M. M. Malone, D. R. Pitter, S. T. Weiss, G. A. Hawkins, S. B. Liggett, Common ADRB2 haplotypes derived from 26 polymorphic sites direct beta2-adrenergic receptor expression and regulation phenotypes. PLoS ONE 5, e11819 (2010).
15. K. M. Small, D. W. McGraw, S. B. Liggett, Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu. Rev. Pharmacol. Toxicol. 43, 381-411 (2003).
16. J. A. Johnson, S. B. Liggett, Cardiovascular pharmacogenomics of adrenergic receptor signaling: Clinical implications and future directions. Clin. Pharmacol. Ther. 89, 366-378 (2011).
17. L. P. Chung, G. Waterer, P. J. Thompson, Pharmacogenetics of β2 adrenergic receptor gene polymorphisms, long-acting β-agonists and asthma. Clin. Exp. Allergy 41, 312-326 (2011).
18. N. Hizawa, Beta-2 adrenergic receptor genetic polymorphisms and asthma. J. Clin. Pharm. Ther. 34, 631-643 (2009).
19. A. A. Litonjua, L. Gong, Q. L. Duan, J. Shin, M. J. Moore, S. T. Weiss, J. A. Johnson, T. E. Klein, R. B. Altman, Very important pharmacogene summary ADRB2. Pharmacogenet. Genomics 20, 64-69 (2010).
20. 2- adrenergic receptor. Sci. Signal. 4, ra53 (2011).
21. A. Salahpour, H. Bonin, S. Bhalla, U. Petäjä-Repo, M. Bouvier, Biochemical characterization of beta2-adrenergic receptor dimers and oligomers. Biol. Chem. 384, 117-123 (2003).
22. T. H. Lan, S. Kuravi, N. A. Lambert, Internalization dissociates β2-adrenergic receptors. PLoS ONE 6, e17361 (2011).
23. B. P. Head, H. H. Patel, D. M. Roth, N. C. Lai, I. R. Niesman, M. G. Farquhar, P. A. Insel, G-protein-coupled receptor signaling components localize in both sarcolemmal and intracellular caveolin-3- associated microdomains in adult cardiac myocytes. J. Biol. Chem. 280, 31036-31044 (2005).
24. S. M. Pontier, Y. Percherancier, S. Galandrin, A. Breit, C. Galés, M. Bouvier, Cholesterol-dependent separation of the beta2-adrenergic receptor from its partners determines signaling efficacy: Insight into nanoscale organization of signal transduction. J. Biol. Chem. 283, 24659-24672 (2008).
25. J. Tao, C. C. Malbon, G-protein-coupled receptor-associated A-kinase anchoring proteins AKAP5 and AKAP12: Differential signaling to MAPK and GPCR recycling. J. Mol. Signal. 3, 19 (2008).
26. Y. K. Xiang, Compartmentalization of β-adrenergic signals in cardiomyocytes. Circ. Res. 109, 231-244 (2011).
27. S. Galandrin, M. Bouvier, Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy. Mol. Pharmacol. 70, 1575-1584 (2006).
28. N. Eswar, D. Eramian, B. Webb, M. Y. Shen, A. Sali, Protein structure modeling with MODELLER. Methods Mol. Biol. 426, 145-159 (2008).
29. Delano Scientific, The PyMOL Molecular Graphics System MacPyMOL (Delano Scientific, Palo Alto, CA, 2009)
30. Acknowledgments: A. Wilderman helped to prepare the draft of Fig. 2. Funding: Work in the author's laboratory is supported by grants from NIH.